tiprankstipranks
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market
VRAX
Virax Biolabs Group Ltd. Class A
RESEARCH TOOLSreports

Virax Biolabs Group Ltd. Class A (VRAX) Financial Statements

166 Followers

Virax Biolabs Group Ltd. Class A Financial Overview

Virax Biolabs Group Ltd. Class A's market cap is currently $3.25M. The company's EPS TTM is $; its P/E ratio is -0.25; Virax Biolabs Group Ltd. Class A is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Sep 22
Income Statement
Total Revenue$ 12.42K$ 6.33K$ 156.42K-$ 0.00
Gross Profit$ 7.69K$ -53.07K$ 50.59K-$ 0.00
Operating Income$ -6.40M$ -6.16M$ -6.50M$ -5.73M$ -1.73M
EBITDA$ -6.05M$ -5.80M$ -6.61M$ -5.44M$ -750.00
Net Income$ -5.02M$ -6.06M$ -6.73M$ -5.46M$ -1.71M
Balance Sheet
Cash & Short-Term Investments$ 6.52M$ 4.23M$ 3.59M$ 9.35M$ 21.76K
Total Assets$ 8.32M$ 6.43M$ 5.48M$ 9.81M$ 48.71K
Total Debt$ 414.39K$ 377.00K$ 224.30K$ 146.25K$ 3.76K
Net Debt$ -6.02M$ -3.85M$ -3.36M$ -9.21M$ -18.00K
Total Liabilities$ 989.83K$ 964.75K$ 345.19K$ 908.40K$ 1.25M
Stockholders' Equity$ 7.58M$ 5.70M$ 5.37M$ 9.13M$ -974.58K
Cash Flow
Free Cash Flow$ -4.88M$ -5.17M$ -7.41M$ -4.36M$ -809.07K
Operating Cash Flow$ -4.62M$ -4.56M$ -6.25M$ -4.18M$ -809.07K
Investing Cash Flow$ -255.83K$ -603.89K$ -1.16M$ -178.40K$ 0.00
Financing Cash Flow$ 7.09M$ 5.81M$ 1.65M$ 13.69M$ 813.21K
Currency in USD

Virax Biolabs Group Ltd. Class A Earnings and Revenue History

Income Statement >

Virax Biolabs Group Ltd. Class A Debt to Assets

Balance Sheet >

Virax Biolabs Group Ltd. Class A Cash Flow

Cash Flow >

Virax Biolabs Group Ltd. Class A Forecast EPS vs Actual EPS

Earnings >